The NEJM study puts countries like ours in a bit of a spot. In India, as in several other countries, families of Covid-19 patients have been asked to take hydroxychloroquine as a preventive drug. The ICMR last month extended the use of this drug as prophylaxis after it found through observational studies that the drug did not have much side effect.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gYkPZd
via IFTTT
0 comments:
Post a Comment